Innovative Oncology Solutions Unveiled by Powered Research
Expanding Horizons: Powered Research's New Oncology Services
For over a decade, Powered Research has earned its reputation as a premier preclinical contract research organization (CRO), particularly in the field of ophthalmology. Today, the company takes a monumental step forward by launching an extensive suite of oncology preclinical services. This new direction is set to redefine the landscape of cancer research and align with the latest advancements within the industry.
Commitment to Excellence in Oncology Services
At the American Association for Cancer Research (AACR) Annual Meeting, Powered Research will proudly showcase its cutting-edge oncology research services, tailored to meet the intricate demands of life sciences research and development. Their dedicated team has recognized the unique challenges posed in oncology research and has responded by integrating over 130 years of combined expertise into their offerings. This commitment is not only a boost for the company but a significant advancement for cancer research overall.
Words from Leadership
David Culp, the Senior Vice President of Powered Research, expressed excitement about this new venture, noting that their extensive experience as a CRO has now extended into oncology, adding a wealth of knowledge and capability. "In late 2023, we initiated investments into oncology services,” said Culp. "We're enthusiastic about introducing this first array of oncology solutions, which includes diverse and sophisticated models tailored for drug development. We genuinely look forward to collaborating with sponsors seeking innovative oncology therapies."
A Legacy of Impact in Oncology
Beth Hollister, VP of Operations, reflects on her rich history in oncology. With over 25 years of experience in this sector, she aims to leverage her past successes to impact cancer treatments positively. “Our mission was to make a remarkable difference in the lives of cancer patients, and with Powered Research, we can keep that legacy alive,” Hollister noted. The commitment and shared knowledge of the Piedmont Research Center team further enrich the company's foundation by incorporating invaluable lessons learned from thousands of successful studies.
Comprehensive Suite of Services
Powered Research offers a variety of oncology preclinical services ranging from experimental design to in vivo tumor modeling and endpoint analyses. Their services are crafted to provide a thorough and expedient evaluation of potential cancer therapeutics. The full scope of capabilities includes:
- Traditional and innovative human tumor xenograft and syngeneic modeling
- Surgical and orthotopic models for tailored research
- Comprehensive evaluations of radiopharmaceutical therapies
- Advanced flow cytometry with extensive immunophenotyping
- Cytokine analysis across various biological samples
- In-house tissue embedding and sectioning services
- A variety of histology services including IHC/IF and more
- State-of-the-art microscopy techniques and analytics
Expert Leadership Driving Innovation
The growing oncology division at Powered Research is led by experts who not only understand the science but are passionate about making a change:
- Beth Hollister – VP of Operations: With her deep expertise in oncology, Hollister is excited to lead a team committed to turning research into actionable results.
- Dr. David Culp – Sr. Vice President: Dr. Culp oversees scientific programs and is enthusiastic about marrying rigorous scientific methodology with state-of-the-art cancer research.
- Kay Meshaw – Sr. Study Director: Kay's extensive experience ensures every study phase is meticulously designed and executed to meet objectives and timelines.
- Joey Kolb, PhD – Research Scientist: Dr. Kolb’s specialty in flow cytometry allows for innovative designs that enhance understanding of immune responses in cancer therapy.
Highlighted Participation at AACR
At AACR, Powered Research will present a remarkable spectral cytometry panel intended for analyzing significant immune cell populations in mouse cancer models. During the meeting, the team will share insights into how spectral flow cytometry can provide solutions to today's research challenges, further demonstrating their commitment to cutting-edge science in oncology.
About Powered Research
Powered Research is dedicated to pioneering research in both ophthalmology and oncology. The organization prides itself on its rapid study turnaround and the ability to create tailored preclinical data packages that meet the specific needs of their clients. The proactive approach ensures timely execution of studies that support extensive experimental goals. Their ongoing development of proprietary models reflects their commitment to innovation and excellence in preclinical research.
Frequently Asked Questions
What are the newly launched services by Powered Research?
Powered Research has launched a suite of oncology preclinical services that include innovative tumor models, flow cytometry technologies, and comprehensive endpoint analyses.
Who leads the oncology services at Powered Research?
The oncology services are led by Beth Hollister, Dr. David Culp, and a team of experienced professionals with extensive backgrounds in oncology research.
What can sponsors expect at the AACR Annual Meeting?
Sponsors visiting Powered Research at AACR can expect to learn about the latest advancements in oncology preclinical research and view their innovative solutions at Booth #3154.
How does Powered Research ensure quality in their studies?
Powered Research maintains high standards through rigorous scientific methodologies and quick turnaround times for their research projects.
What is Powered Research known for in the industry?
Powered Research is known for its excellence in preclinical research, particularly in rapid study execution while maintaining superior data quality.
About The Author
Contact Olivia Taylor privately here. Or send an email with ATTN: Olivia Taylor as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.